CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
FragNet focuses on training researchers in fragment-based lead discovery, a method that enhances drug development by optimizing low molecular weight compounds that bind to target proteins. This multidisciplinary approach aims to advance pharmaceutical sciences.
The promise of more efficient lead discovery is fuelling the enthusiasm for fragment-based lead discovery (FBLD).
In this approach, highly sensitive biochemical and biophysical screening technologies are being used to detect the low affinity binding of low molecular weight compounds (the so-called fragments) to protein targets that are involved in pathophysiological processes.
By investigating the molecular interactions between fragment hit(s) and the target protein, a detailed understanding of…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, York North Yorkshire
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Barcelona
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Cambridge
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
